Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics

Sponsor
Bausch & Lomb Incorporated (Industry)
Overall Status
Completed
CT.gov ID
NCT00198549
Collaborator
(none)
40
1
5.9
6.7

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate Vitrase as an adjuvant to increase absorption and dispersion of other injected anesthetics

Condition or Disease Intervention/Treatment Phase
  • Drug: Vitrase (ovine hyaluronidase) Lyophilized
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Phase IV Post-Approval Evaluation of Vitrase as an Adjuvant to Increase the Absorption and Dispersion of Other Injected Anesthetics for Ophthalmic Surgical Procedures
Study Start Date :
Sep 1, 2004
Actual Primary Completion Date :
Jan 1, 2005
Actual Study Completion Date :
Mar 1, 2005

Outcome Measures

Primary Outcome Measures

  1. To evaluate physician acceptance of efficacy of Vitrase as an adjuvant to increase absorption and dispersion of anesthetics used for ophthalmic surgical procedures []

Secondary Outcome Measures

  1. To determine physician usage of and satisfaction with Vitrase in the 6200 USP unit vial []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Scheduled for an ophthalmic surgical procedure
Exclusion Criteria:
  • Known allergy to bee venom

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cincinnati Eye Institute Cincinnati Ohio United States 45242

Sponsors and Collaborators

  • Bausch & Lomb Incorporated

Investigators

  • Study Director: Lisa R Grillone, PhD, ISTA Pharmaceuticals, Inc.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bausch & Lomb Incorporated
ClinicalTrials.gov Identifier:
NCT00198549
Other Study ID Numbers:
  • ISTA-VIT-SA-MA02
First Posted:
Sep 20, 2005
Last Update Posted:
Mar 19, 2013
Last Verified:
Mar 1, 2013
Keywords provided by Bausch & Lomb Incorporated

Study Results

No Results Posted as of Mar 19, 2013